Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.495
+0.025 (0.56%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Exagen Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Exagen stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 66.85% from the current stock price of 4.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Exagen stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | +77.98% | Jan 13, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +55.73% | Jan 3, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +55.73% | May 14, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +33.48% | Sep 26, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +33.48% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
65.32M
from 55.64M
Increased by 17.40%
Revenue Next Year
75.14M
from 65.32M
Increased by 15.04%
EPS This Year
-0.57
from -0.83
EPS Next Year
-0.30
from -0.57
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 69.4M | 79.0M | 89.0M | ||
Avg | 65.3M | 75.1M | 85.6M | ||
Low | 62.6M | 71.5M | 83.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 24.7% | 20.9% | 18.5% | ||
Avg | 17.4% | 15.0% | 14.0% | ||
Low | 12.5% | 9.5% | 10.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.56 | -0.24 | -0.19 | ||
Avg | -0.57 | -0.30 | -0.18 | ||
Low | -0.60 | -0.37 | -0.18 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.